Li Lanjuan
State Key Laboratory for Diagnosis and Treatment of Infectious Diseases, The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China.
Infect Microbes Dis. 2020 Apr 17. doi: 10.1097/IM9.0000000000000021.
The prevention and treatment of COVID-19 nationwide has entered a tackling phase. Effective treatment of severe and critically ill patients is the key to reducing the fatality of the disease. The artificial liver blood purification system can remove inflammatory factors, alleviate the damage of the inflammatory response to the body, and has important value for the treatment of severe COVID-19. Led by Academician Lanjuan Li, based on the experience of treating patients across the country, integrating the opinions of experts from all over the country, the center summarized and formulated the consensus including the basic principles, treatment indications, relative contraindications, mode selection, monitoring indicators, and efficacy evaluation of artificial liver, which provides reference for treatment of severe COVID-19 patients.
全国新冠肺炎防治已进入攻坚阶段。有效救治重症和危重症患者是降低该病病死率的关键。人工肝血液净化系统可清除炎症因子,减轻炎症反应对机体的损害,对重症新冠肺炎治疗具有重要价值。在李兰娟院士的带领下,中心基于全国救治患者的经验,综合全国专家意见,总结制定了人工肝的基本原则、治疗指征、相对禁忌证、模式选择、监测指标及疗效评估等共识,为重症新冠肺炎患者的治疗提供参考。